Effects of low molecular weight heparin on clot rate and activated clotting time: An in vitro study

Chinese Medical Journal

Volumn 126, Issue 18, 2013, Pages 3553-3556

  Shi, Xu Bo ^a   Bai, Ying ^a   Li, Jie ^a   Xiao, Jie ^a   Wang, Jian Qi ^a   Zheng, Hua ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Activated clotting time; Clot rate; Low molecular weight heparin

Indexed keywords

COAGULATING AGENT; DALTEPARIN; INFUSORIAL EARTH; KAOLIN; LOW MOLECULAR WEIGHT HEPARIN; MAGNETIC BAR; UNCLASSIFIED DRUG;

ACTIVATED CLOTTING TIME; ADULT; ANTICOAGULATION; ARTICLE; BLOOD CLOT RATE; BLOOD CLOTTING PARAMETERS; BLOOD CLOTTING TIME; DRUG EFFECT; FEMALE; GLASS BEAD; HUMAN; LINEAR REGRESSION ANALYSIS; MALE; NORMAL HUMAN; VENOUS BLOOD;

ADULT; ANTICOAGULANTS; BLOOD COAGULATION; BLOOD COAGULATION TESTS; FEMALE; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; MALE; MIDDLE AGED;

EID: 84884254466     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.20131580     Document Type: Article

References (17)

1. Garcia DA, Baglin TP, Weitz JI, Samama MM, American College of Chest Physicians. Parenteral anticoagulants: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012; 141 (2 Suppl): e24S-e43S.
2. Nutescu EA, Spinler SA, Wittkowsky A, Dager W. Low-molecular-weight heparins in renal impairment and obesity: available evidence and clinical practice recommendations across medical and surgical settings. Ann Pharmacother 2009; 43: 1064-1083.
3. Clark NP. Low-molecular-weight heparin use in the obese, elderly, and in renal insufficiency. Thromb Res 2008; 123 Suppl 1: S58-S61.
4. Yan HB, Song L, Liu R, Zhao HJ, Wang SP, Chi YP, et al. Comparison of safety and efficacy between fondaparinux and nadroparin in non-ST elevation acute coronary syndromes. Chin Med J 2011; 124: 879-886.
5. Shen WF. Evolution of interventional cardiology in China. Chin Med J 2009; 122: 2209-2219.
6. Sinauridze EI, Panteleev MA, Ataullakhanov FI. Anticoagulant therapy: basic principles, classic approaches and recent developments. Blood Coagul Fibrinolysis 2012; 23: 482-493.
7. Lim W. Using low molecular weight heparin in special patient populations. J Thromb Thrombolysis 2010; 29: 233-240.
8. Fabbian F, De Giorgi A, Pala M, Tiseo R, Portaluppi F, Imberti D, et al. Low molecular weight heparins and glomerular filtration rate: a report to be considered. Curr Vasc Pharmacol 2011; 9: 693-697.
9. Hattersley PG. Activated coagulation time of whole blood. JAMA 1966; 196: 436-440.
10. Furuhashi M, Ura N, Hasegawa K, Yoshida H, Tsuchihashi K, Miura T, et al. Sonoclot coagulation analysis: new bedside monitoring for determination of the appropriate heparin dose during haemodialysis. Nephrol Dial Transplant 2002; 17: 1457-1462.
11. Baglin T, Barrowcliffe TW, Cohen A, Greaves M. British Committee for Standards in Haematology. Guidelines on the use and monitoring of heparin. Br J Haematol 2006; 133: 19-34.
12. Funk DM. Coagulation assays and anticoagulant monitoring. Hematology Am Soc Hematol Educ Program 2012; 2012: 460-465.
13. Ganter MT, Hofer CK. Coagulation monitoring: current techniques and clinical use of viscoelastic point-of-care coagulation devices. Anesth Analg 2008; 106: 1366-1375.
14. Chaudhary V, Chauhan S, Choudhury M, Kiran U, Talwar S, Kapoor PM. Sonoclot analysis in children with congenital heart disease. Asian Cardiovasc Thorac Ann 2012; 20: 544-547.
15. Kitchen S, Jennings I, Woods TA, Preston FE. Wide variability in the sensitivity of APTT reagents for monitoring of heparin dosage. J Clin Pathol 1996; 49: 10-14.
16. Fritsma GA, Dembitzer FR, Randhawa A, Marques MB, Van Cott EM, Adcock-Funk D, et al. Recommendations for appropriate activated partial thromboplastin time reagent selection and utilization. Am J Clin Pathol 2012; 137: 904-908.
17. Henry TD, Satran D, Knox LL, Iacarella CL, Laxson DD, Antman EM. Are activated clotting times helpful in the management of anticoagulation with subcutaneous low-molecular-weight heparin? Am Heart J 2001; 142: 590-593.